The Ongoing Clinical Studies and Trials for Myelodysplastic Syndrome are Expected to Provide a New Dimension to MDS Care in the Coming Years.
In spite of several approved therapies, the currently the Myelodysplastic Syndrome Therapeutics market faces high unmet medical needs. In order to provide effective therapeutics options, some of the key companies in the domain such as Astex Pharmaceuticals, Onconova Therapeutics, Celgene, Aprea Therapeutics, Celyad, and others are actively involved in developing therapies. Apart from the therapeutics […]
The post The Ongoing Clinical Studies and Trials for Myelodysplastic Syndrome are Expected to Provide a New Dimension to MDS Care in the Coming Years. appeared first on Financial Market Brief.

